Resynchronization-defibrillation for heart failure shows long-term benefits
Cardiology Update
JANUARY 22, 2024
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). Original article: Sapp JL et al.
Let's personalize your content